Brca1L63X/+ rat is a novel model of human BRCA1 deficiency displaying susceptibility to radiation‐induced mammary cancer
Open Access
- 21 August 2022
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 113 (10) , 3362-3375
Abstract
Women who are heterozygous for deleterious BRCA1 germline mutations harbor a high risk of hereditary breast cancer. Previous Brca1‐heterozygous animal models do not recapitulate the breast cancer phenotype, and thus all currently used knockout models adopt conditional, mammary‐specific homozygous Brca1 loss or addition of Trp53 deficiency. Herein, we report the creation and characterization of a novel Brca1 mutant rat model harboring the germline L63X mutation, which mimics a founder mutation in Japan, through CRISPR‐Cas9–based genome editing. Homozygotes (Brca1L63X/L63X) were embryonic lethal, whereas heterozygotes (Brca1L63X/+) showed apparently normal development. Without carcinogen exposure, heterozygotes developed mammary carcinoma at a comparable incidence rate with their wild‐type (WT) littermates during their lifetime. Intraperitoneal injection of 1‐methyl‐1‐nitrosourea (25 or 50 mg/kg) at 7 weeks of age induced mammary carcinogenesis at comparable levels among the heterozygotes and their littermates. After exposure to ionizing radiation (0.1–2 Gy) at 7 weeks of age, the heterozygotes, but not WT littermates, displayed dose‐dependent mammary carcinogenesis with 0.8 Gy−1 excess in hazard ratio during their middle age; the relative susceptibility of the heterozygotes was more prominent when rats were irradiated at 3 weeks of age. The heterozygotes had tumors with a lower estrogen receptor α immunopositivity and no evidence of somatic mutations of the WT allele. The Brca1L63X/+ rats thus offer the first single‐mutation, heterozygous model of BRCA1‐associated breast cancer, especially with exposure to a DNA break‐inducing carcinogen. This implies that such carcinogens are causative and a key to breast cancer prevention in individuals who carry high‐risk BRCA1 mutations.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP15H02824, JP21H03601, JP26550036)
This publication has 44 references indexed in Scilit:
- Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)BMJ, 2012
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEffFly, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancersBreast Cancer Research, 2010
- Impaired Skin and Mammary Gland Development and Increased γ-Irradiation–Induced Tumorigenesis in Mice Carrying a Mutation of S1152-ATM Phosphorylation Site in Brca1Cancer Research, 2009
- Preclinical mouse models for BRCA1-associated breast cancerBritish Journal of Cancer, 2009
- Epithelial ovarian cancer: Focus on genetics and animal modelsCell Cycle, 2009
- Mouse models for BRCA1 associated tumorigenesis: From fundamental insights to preclinical utilityCell Cycle, 2008
- A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung CancerThe Journal of Molecular Diagnostics, 2006
- BRCA1 in hormonal carcinogenesis: basic and clinical researchEndocrine-Related Cancer, 2005